Multicare Institute for Research and Innovation

Puyallup, Washington 98372

1 studies enrolling now · 6 studies all time

What they study most

ASCVD, Carcinoma, Ovarian Epithelial, Coronary Heart Disease (CHD), Fallopian Tube Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Serous Adenocarcinoma, Metastatic Breast Cancer, Ovarian Cancer, Ovarian Neoplasms, Ovarian Serous Adenocarcinoma, Percutaneous Coronary Intervention, Peripheral Endovascular Intervention

Studies at this site

• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — Running, not enrolling
• Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer — Stopped early
• Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer — Withdrawn before enrolling
• The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early